In recent months, several blood pressure medications have been recalled, and recently, two more have been added to the list.
Teva Pharmaceuticals Volunteers The US Food and Drug Administration announced on Tuesday its announcement of the combination of amlodipine / valsartan and amlodipine / valsartan / hydrochlorothiazide.
>> Read the full recall notice from the FDA
. Nitrosodiethylamine, a chemical manufactured in Mylan, India. The ingredient that is typically found in certain foods, drinking water and air pollution has been classified as a human carcinogen by the International Agency for Research on Cancer.
Teva officials found that the company has not received any reports of illness, but it has asked its retailers to stop distributing the products and return them immediately.
Patients treated with the medications are advised to continue taking the pills and ask their doctor for alternative treatments. A company official said, "The risk of a patient's health risk may be higher if treatment is discontinued immediately without comparable alternative treatment."
[RELATED: Yet another blood pressure medication recalled over cancer risk]
The agency recently recalled three other blood pressure medicines due to cancer, and another was recalled because of false labeling.